SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-033032
Filing Date
2024-04-15
Accepted
2024-04-15 17:19:49
Documents
16
Period of Report
2024-04-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0203936-8k_biomxinc.htm   iXBRL 8-K 37284
2 AMENDED AND RESTATED BYLAWS OF THE COMPANY, AS AMENDED ON APRIL 11, 2024 ea020393601ex3-1_biomxinc.htm EX-3.1 73672
3 AMENDED AND RESTATED BYLAWS OF THE COMPANY, AS AMENDED ON APRIL 11, 2024 (MARKED ea020393601ex3-2_biomxinc.htm EX-3.2 74439
  Complete submission text file 0001213900-24-033032.txt   449553

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE phge-20240411.xsd EX-101.SCH 3919
5 XBRL DEFINITION FILE phge-20240411_def.xml EX-101.DEF 26852
6 XBRL LABEL FILE phge-20240411_lab.xml EX-101.LAB 37192
7 XBRL PRESENTATION FILE phge-20240411_pre.xml EX-101.PRE 25476
19 EXTRACTED XBRL INSTANCE DOCUMENT ea0203936-8k_biomxinc_htm.xml XML 6273
Mailing Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38762 | Film No.: 24845490
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)